A pattern of multiple generic decision trees

CNS tumours

Clinical implications of the 2021 WHO classification

Announcements

Advertisement

Treatment of multiple sclerosis

The first disease-modifying therapy for relapsing–remitting multiple sclerosis — interferon‑β 1b — was approved by the FDA in 1993. The following 25 years have seen rapid expansion of the therapeutic options as an evolving understanding of the disease has enabled development of therapies with different modes of action.
Milestone

Advertisement

Nature Careers

Events

Jobs

Advertisement